EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
1972 • 31,801 citations
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 • 2,055 citations
Cholesterol determination in high-density lipoproteins separated by three different methods.
1977 • 1,857 citations
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
1980 • 1,607 citations
Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.
1980 • 1,195 citations
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
1984 • 764 citations
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
1969 • 623 citations
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
1983 • 562 citations
Diet, Lipoproteins, and the Progression of Coronary Atherosclerosis
1985 • 494 citations
Defective Lipoprotein Receptors and Atherosclerosis
1983 • 469 citations
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
1981 • 424 citations
Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia
1981 • 262 citations
Therapeutic effects of ML-236B in primary hypercholesterolemia
1980 • 231 citations
A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein.
1980 • 218 citations
Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.
1985 • 210 citations
Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
1982 • 206 citations
Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia
1983 • 201 citations
Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
1981 • 197 citations
Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
1984 • 176 citations
Diet, Lipoproteins and the Progression of Coronary Atherosclerosis
1986 • 148 citations
Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia
1984 • 132 citations
Manual and Semi-Automated Procedures for Measurement of Triglycerides in Serum
1975 • 114 citations
Influence of Combined Therapy with Mevinolin and Interruption of Bile-Acid Reabsorption on Low Density Lipoproteins in Heterozygous Familial Hypercholesterolemia
1985 • 108 citations
Five methods for determining low-density lipoprotein cholesterol compared.
1984 • 104 citations
Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia
1986 • 86 citations
Familial Hypercholesterolemia
1982 • 58 citations
An improved semi-automated method for the colorimetric determination of triglycerides in serum
1975 • 37 citations